News

BioWorld Today: Financings Roundup- Esperion Therapeutics

June 14, 2013 - BioWorld Today

Esperion Therapeutics Inc., of Plymouth, Mich., fi led terms for its initial public offering, planning to raise $63 million by offering 4.5 million shares at a price range of $13 to $15. The company would list under the symbol “ESPR.”